Shuttle Pharmaceuticals Stock Technical Analysis
| SHPH Stock | USD 0.95 0.06 6.76% |
As of the 4th of March, Shuttle Pharmaceuticals has the Variance of 89.39, insignificant risk adjusted performance, and Coefficient Of Variation of (5,856). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Shuttle Pharmaceuticals, as well as the relationship between them.
Shuttle Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Shuttle, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ShuttleShuttle Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Biotechnology market expansion? Will Shuttle introduce new products? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Shuttle Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Shuttle Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Shuttle Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Shuttle Pharmaceuticals.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Shuttle Pharmaceuticals on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Shuttle Pharmaceuticals or generate 0.0% return on investment in Shuttle Pharmaceuticals over 90 days. Shuttle Pharmaceuticals is related to or competes with Akanda Corp, Heart Test, Universe Pharmaceuticals, Theriva Biologics, Biovie, ISpecimen, and Redhill Biopharma. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery,... More
Shuttle Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Shuttle Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Shuttle Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 55.61 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 15.69 |
Shuttle Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shuttle Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Shuttle Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Shuttle Pharmaceuticals historical prices to predict the future Shuttle Pharmaceuticals' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | 0.1209 |
Shuttle Pharmaceuticals March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | 0.1309 | |||
| Mean Deviation | 6.88 | |||
| Coefficient Of Variation | (5,856) | |||
| Standard Deviation | 9.45 | |||
| Variance | 89.39 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | 0.1209 | |||
| Maximum Drawdown | 55.61 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 15.69 | |||
| Skewness | 0.13 | |||
| Kurtosis | 1.84 |
Shuttle Pharmaceuticals Backtested Returns
Shuttle Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0533, which indicates the firm had a -0.0533 % return per unit of risk over the last 3 months. Shuttle Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Shuttle Pharmaceuticals' Coefficient Of Variation of (5,856), insignificant risk adjusted performance, and Variance of 89.39 to confirm the risk estimate we provide. The entity has a beta of -1.42, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Shuttle Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Shuttle Pharmaceuticals is expected to outperform it. At this point, Shuttle Pharmaceuticals has a negative expected return of -0.5%. Please make sure to validate Shuttle Pharmaceuticals' value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Shuttle Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.08 |
Very weak reverse predictability
Shuttle Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Shuttle Pharmaceuticals time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Shuttle Pharmaceuticals price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Shuttle Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
Shuttle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Shuttle Pharmaceuticals Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Shuttle Pharmaceuticals across different markets.
About Shuttle Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Shuttle Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Shuttle Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Shuttle Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Shuttle Pharmaceuticals. By analyzing Shuttle Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Shuttle Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Shuttle Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Shuttle Pharmaceuticals March 4, 2026 Technical Indicators
Most technical analysis of Shuttle help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Shuttle from various momentum indicators to cycle indicators. When you analyze Shuttle charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | 0.1309 | |||
| Mean Deviation | 6.88 | |||
| Coefficient Of Variation | (5,856) | |||
| Standard Deviation | 9.45 | |||
| Variance | 89.39 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | 0.1209 | |||
| Maximum Drawdown | 55.61 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 15.69 | |||
| Skewness | 0.13 | |||
| Kurtosis | 1.84 |
Shuttle Pharmaceuticals March 4, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Shuttle stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.07 | ||
| Day Median Price | 0.92 | ||
| Day Typical Price | 0.93 | ||
| Price Action Indicator | 0.06 | ||
| Market Facilitation Index | 0.06 |
Complementary Tools for Shuttle Stock analysis
When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |